Author

Amélie Sauty De Chalon

Observed name: Amelie Sauty de Chalon

Institutions: Novartis (Switzerland), Novartis Institutes for BioMedical Research

Observed institutions: Novartis (Switzerland), Centre National de la Recherche Scientifique, Inserm, Université de Lyon, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon, Novartis Institutes for BioMedical Research

OpenAlex ID: A5045933730

Linking Phenotypes and Modes of Action Through High-Content Screen Fingerprints

2015 · Felix Reisen, Amelie Sauty de Chalon, et al. · Assay and Drug Development Technologies · 79

Inhibition of IGF-1 Signalling Enhances the Apoptotic Effect of AS602868, an IKK2 Inhibitor, in Multiple Myeloma Cell Lines

2011 · Ines Tagoug, Amélie Sauty De Chalon, et al. · PLoS ONE · 19

Works count: 2

Citation count: 98

H-index: 2

I10-index: 2